Michael V. Berridge

10.9k total citations · 2 hit papers
124 papers, 7.4k citations indexed

About

Michael V. Berridge is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael V. Berridge has authored 124 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 34 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Michael V. Berridge's work include Cancer, Hypoxia, and Metabolism (25 papers), Mitochondrial Function and Pathology (20 papers) and ATP Synthase and ATPases Research (12 papers). Michael V. Berridge is often cited by papers focused on Cancer, Hypoxia, and Metabolism (25 papers), Mitochondrial Function and Pathology (20 papers) and ATP Synthase and ATPases Research (12 papers). Michael V. Berridge collaborates with scholars based in New Zealand, Australia and United States. Michael V. Berridge's co-authors include An S. Tan, Patries M. Herst, Nuzhat Ahmed, Kathy D. McCoy, Rui Wang, John K. Fraser, Matthew R. Rowe, Peter T. Northcote, Kylie Hood and Jiřı́ Neužil and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Michael V. Berridge

123 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction

2005 1.7k citations Michael V. Berridge, Patries M. Herst et al. PubMed profile →
Characterization of the Cellular Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular Localization, Substrate Dependence, and Involvement of Mitochondrial Electron Transport in MTT Reduction

1993 1.2k citations Michael V. Berridge, An S. Tan profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael V. Berridge New Zealand	41	3.3k	995	839	707	625	124	7.4k
Angelika M. Vollmar Germany	56	4.2k 1.3×	686 0.7×	821 1.0×	924 1.3×	886 1.4×	243	9.8k
Yanan Wang China	44	3.8k 1.2×	785 0.8×	1.0k 1.2×	896 1.3×	636 1.0×	489	8.4k
Fusao Tomita Japan	43	3.7k 1.1×	965 1.0×	433 0.5×	356 0.5×	342 0.5×	177	7.3k
Kazuo Nagai Japan	48	4.1k 1.3×	955 1.0×	575 0.7×	1.1k 1.5×	360 0.6×	202	7.0k
Zichun Hua China	43	3.8k 1.2×	357 0.4×	869 1.0×	937 1.3×	1.1k 1.7×	300	7.6k
Jisnuson Svasti Thailand	41	2.9k 0.9×	544 0.5×	382 0.5×	460 0.7×	518 0.8×	295	5.6k
Dunyaporn Trachootham Thailand	19	4.6k 1.4×	912 0.9×	1.4k 1.6×	1.0k 1.4×	508 0.8×	52	8.4k
Yue Chen China	36	2.8k 0.8×	596 0.6×	903 1.1×	599 0.8×	428 0.7×	217	5.0k
William DeGraff United States	45	4.7k 1.4×	1.2k 1.2×	1.4k 1.6×	1.7k 2.4×	1.1k 1.7×	100	10.9k
Stefan Zahler Germany	45	2.8k 0.9×	439 0.4×	657 0.8×	715 1.0×	1.2k 1.9×	190	7.6k

Countries citing papers authored by Michael V. Berridge

Since Specialization

Citations

This map shows the geographic impact of Michael V. Berridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Berridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Berridge more than expected).

Fields of papers citing papers by Michael V. Berridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. Berridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Berridge. The network helps show where Michael V. Berridge may publish in the future.

Co-authorship network of co-authors of Michael V. Berridge

This figure shows the co-authorship network connecting the top 25 collaborators of Michael V. Berridge. A scholar is included among the top collaborators of Michael V. Berridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael V. Berridge. Michael V. Berridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berridge, Michael V., Renata Zobalová, Štěpána Boukalová, et al.. (2025). Horizontal mitochondrial transfer in cancer biology: Potential clinical relevance. Cancer Cell. 43(5). 803–807. 6 indexed citations

Berridge, Michael V., Patries M. Herst, & Cecilia Prata. (2023). Cellular reductive stress: Is plasma membrane electron transport an evolutionarily-conserved safety valve?. SHILAP Revista de lepidopterología. 5-6. 100016–100016. 4 indexed citations

Ezrova, Zuzana, Zuzana Nahácka, Jan Štursa, et al.. (2021). SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. Oncogene. 40(14). 2539–2552. 27 indexed citations

Woodhead, Jonathan S. T., Randall F. D’Souza, Christopher P. Hedges, et al.. (2020). High-intensity interval exercise increases humanin, a mitochondrial encoded peptide, in the plasma and muscle of men. Journal of Applied Physiology. 128(5). 1346–1354. 45 indexed citations

Grasso, Carole, Matthew Anaka, Oliver Hofmann, et al.. (2016). Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations. BMC Cancer. 16(1). 726–726. 15 indexed citations

Baty, James W., Michael V. Berridge, Andrew B. Munkacsi, et al.. (2016). N,N-Bis(glycityl)amines as anti-cancer drugs. Bioorganic & Medicinal Chemistry. 24(17). 3932–3939. 5 indexed citations

Campbell, Heather, Claire Vennin, Michelle Wilson, et al.. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene. 35(38). 4981–4989. 30 indexed citations

Berridge, Michael V., Patries M. Herst, & Alfons Lawen. (2008). Targeting mitochondrial permeability in cancer drug development. Molecular Nutrition & Food Research. 53(1). 76–86. 30 indexed citations

Berridge, Michael V. & Morré Dj. (2008). Plasma membrane redox and cancer drug development. Preface.. PubMed. 34(3). 181–2. 1 indexed citations

10.

Berridge, Michael V., et al.. (2007). Interaction of heme and heme–hemopexin with an extracellular oxidant system used to measure cell growth-associated plasma membrane electron transport. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1767(9). 1107–1117. 11 indexed citations

11.

Herst, Patries M. & Michael V. Berridge. (2006). Cell surface oxygen consumption: A major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1767(2). 170–177. 146 indexed citations

12.

Herst, Patries M. & Michael V. Berridge. (2006). Plasma Membrane Electron Transport: A New Target for Cancer Drug Development. Current Molecular Medicine. 6(8). 895–904. 51 indexed citations

13.

Miller, John H., Thomas N. Gaitanos, Kylie Hood, et al.. (2004). Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells. APOPTOSIS. 9(6). 785–796. 33 indexed citations

14.

Tan, An S. & Michael V. Berridge. (2004). Distincttrans-plasma membrane redox pathways reduce cell-impermeable dyes in HeLa cells. Redox Report. 9(6). 302–306. 24 indexed citations

15.

Berridge, Michael V., et al.. (2000). Ceramides that Mediate Apoptosis Reduce Glucose Uptake and Transporter Affinity for Glucose in Human Leukaemic Cell Lines but Not in Neutrophils. Pharmacology & Toxicology. 86(3). 114–121. 9 indexed citations

16.

Ahmed, Nuzhat & Michael V. Berridge. (1999). N-Glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells. Leukemia Research. 23(4). 395–401. 28 indexed citations

17.

Berridge, Michael V., et al.. (1995). Conserved Region of the Cytoplasmic Domain is not Essential for Erythropoietin-Dependent Growth. Growth Factors. 12(4). 263–276. 9 indexed citations

18.

Berridge, Michael V. & An S. Tan. (1992). The protein kinase C inhibitor, calphostin C, inhibits succinate-dependent mitochondrial reduction of MTT by a mechanism that does not involve protein kinase C. Biochemical and Biophysical Research Communications. 185(3). 806–811. 10 indexed citations

19.

Dempster, R.P., Michael V. Berridge, G.B.L. Harrison, & D.D. Heath. (1991). Echinococcus granulosus: Development of an intermediate host mouse model for use in vaccination studies. International Journal for Parasitology. 21(5). 549–554. 36 indexed citations

20.

Berridge, Michael V.. (1979). A new class of cell surface antigens. Quantitative absorption studies defining cell-lineage-specific antigens on hemopoietic cells.. The Journal of Experimental Medicine. 150(4). 977–986. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact